The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy
Author Information
Author(s): Aristo Vojdani, Jama Lambert
Primary Institution: Immunosciences Lab., Inc.
Hypothesis
Understanding the role of Th17 cells in autoimmune diseases can help design CAM therapies targeting these cells.
Conclusion
Th17 cells and their cytokines play a significant role in the pathogenesis of neuroimmune disorders, suggesting that targeting them may be beneficial in treatment.
Supporting Evidence
- Th17 cells produce IL-17, which contributes to the pathogenesis of multiple autoimmune diseases.
- Targeting Th17 cells may help repair the intestinal and blood-brain barriers in patients with autoimmunities.
- IL-17 is linked to various inflammatory and autoimmune diseases, including multiple sclerosis.
Takeaway
Th17 cells are a type of immune cell that can cause inflammation and are important in diseases like multiple sclerosis. Finding ways to target these cells could help treat these diseases.
Methodology
The article reviews the role of Th17 cells in autoimmune diseases and discusses potential CAM therapies targeting these cells.
Limitations
The study primarily focuses on the role of Th17 cells without extensive empirical data or clinical trials.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website